of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
in a biology/medical/pharmaceuticals discipline Significant experience working experience with clinical data and analysis Experience of working within the respiratory or immunology fields preferred Extensive experience in attending and covering medical congresses A clear communicator with the ability to communicate complex issues simply A critical, innovative thinker More ❯
in a biology/medical/pharmaceuticals discipline Significant experience working experience with clinical data and analysis Experience of working within the respiratory or immunology fields preferred Extensive experience in attending and covering medical congresses A clear communicator with the ability to communicate complex issues simply A critical, innovative thinker More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology, and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
the scope, purpose and grading of the post. Skills, knowledge and experience Essential Criteria Bachelor’s degree (or higher) in biotechnology, biomedical science, biochemistry, immunology or a related field or proven experience working in quality management systems for medical devices. Strong knowledge and hands on experience with ISO More ❯
is seen as a 'Trusted Partner'. Deploy approved UCB tools and solutions which bring meaningful treatment outcomes for all patients treated with UCB Immunology brands. Demonstrate how UCB can partner to achieve collaborative opportunities supporting NHS operating plans. Build and leverage strong external networks to achieve local NHS business More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
Stevenage, Hertfordshire, United Kingdom Hybrid / WFH Options
GlaxoSmithKline
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
level in a biology/medical/pharmaceuticals discipline. Significant experience working with clinical data and analysis. Experience of working within the respiratory or immunology fields preferred. Extensive experience in attending and covering medical congresses. A clear communicator with the ability to communicate complex issues simply. A critical, innovative thinker … of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
principles of data science, and developing new computational tools to support innovative research and develop novel therapies. We serve five key therapeutic areas: HIV, Immunology, Infections Disease, Oncology, Respiratory, and Vaccines, and offer unlimited growth opportunities and exciting career paths for a wide range of experience levels. Your Role at … of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it More ❯
